Granulocyte colony-stimulating factor (G-CSF) enhances superoxide production in acute liver failure (ALF): an in vivo effect

M Clapperton, J Wendon and N Rolando

Institute of Liver Studies, King's College School of Medicine and Dentistry, London, UK

from 18th International Symposium on Intensive Care and Emergency Medicine
Brussels, Belgium. 17–20 March 1998

Critical Care 1998, 2(Suppl 1):P015doi:10.1186/cc145

Published:

1 March 1998

Methods

The in vitro ability of G-CSF to improve neutrophil superoxide production has been previously demonstrated in ALF patients [1]. However, the in vivo effect on neutrophil function is unknown. Therefore G-CSF was given to three groups of ALF patients (n = 6) as a daily infusion at four different dosages (25, 50, 100 and 150 µg/m²). Superoxide production was measured after fMLP stimulation, before and at 24 and 96 h.

Results

See table

G-CSF significantly enhanced superoxide production at 96 h (P < 0.05). Furthermore, this effect was observed at doses below the standard therapeutic dose of 150 µg/m². Further studies are needed to determine the therapeutic value of G-CSF in the prevention and treatment of infection in ALF patients.

Table.

References

Rolando N, Clapperton M, et al.: Effect of granulocyte colony stimulating factor (G-CSF) on neutrophil function in patients with acute liver failure.
J Hepatol 1996, 25:100.

This article is part of the supplement: 18th International Symposium on Intensive Care and Emergency Medicine

Granulocyte colony-stimulating factor (G-CSF) enhances superoxide production in acute liver failure (ALF): an in vivo effect

Methods

Results

References

Have something to say? Post a comment on this article!